Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Pryce

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Brain Research|July 11, 2006
Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis miceAna Cabranes, Gareth Pryce, David Baker, et al.
Immunology|December 8, 2016
Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosisStephanie von Kutzleben, Gareth Pryce, Gavin Giovannoni, et al.
The Lancet. Neurology|July 10, 2003
The therapeutic potential of cannabisDavid Baker, Gareth Pryce, Gavin Giovannoni, et al.
Plos One|June 30, 2016
Characterisation of Transcriptional Changes in the Spinal Cord of the Progressive Experimental Autoimmune Encephalomyelitis Biozzi ABH Mouse Model by RNA SequencingIoanna Sevastou, Gareth Pryce, David Baker, et al.
Trends in Pharmacological Sciences|December 2, 2005
In silico patent searching reveals a new cannabinoid receptorDavid Baker, Gareth Pryce, Wayne L Davies, et al.
Ebiomedicine|February 6, 2017
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple SclerosisDavid Baker, Monica Marta, Gareth Pryce, et al.
Journal of the Neurological Sciences|May 17, 2005
Cannabinoids and neuroprotection in CNS inflammatory diseaseSamuel J Jackson, Lara T Diemel, Gareth Pryce, et al.
Brain : a Journal of Neurology|September 14, 2018
Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosisDavid Baker, Gareth Pryce, Sandra Amor, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosisDavid Baker, Gareth Pryce, Samuel J Jackson, et al.
Multiple Sclerosis and Related Disorders|June 17, 2017
Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitisEseberuo Sefia, Gareth Pryce, Ute-Christiane Meier, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Brain Research|July 11, 2006
Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis miceAna Cabranes, Gareth Pryce, David Baker, et al.
Immunology|December 8, 2016
Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosisStephanie von Kutzleben, Gareth Pryce, Gavin Giovannoni, et al.
The Lancet. Neurology|July 10, 2003
The therapeutic potential of cannabisDavid Baker, Gareth Pryce, Gavin Giovannoni, et al.
Plos One|June 30, 2016
Characterisation of Transcriptional Changes in the Spinal Cord of the Progressive Experimental Autoimmune Encephalomyelitis Biozzi ABH Mouse Model by RNA SequencingIoanna Sevastou, Gareth Pryce, David Baker, et al.
Trends in Pharmacological Sciences|December 2, 2005
In silico patent searching reveals a new cannabinoid receptorDavid Baker, Gareth Pryce, Wayne L Davies, et al.
Ebiomedicine|February 6, 2017
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple SclerosisDavid Baker, Monica Marta, Gareth Pryce, et al.
Journal of the Neurological Sciences|May 17, 2005
Cannabinoids and neuroprotection in CNS inflammatory diseaseSamuel J Jackson, Lara T Diemel, Gareth Pryce, et al.
Brain : a Journal of Neurology|September 14, 2018
Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosisDavid Baker, Gareth Pryce, Sandra Amor, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosisDavid Baker, Gareth Pryce, Samuel J Jackson, et al.
Multiple Sclerosis and Related Disorders|June 17, 2017
Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitisEseberuo Sefia, Gareth Pryce, Ute-Christiane Meier, et al.
Pageof 7